ArticleJournal for immunotherapy of cancer2019

Evaluating in vivo efficacy - toxicity profile of TEG001 in humanized mice xenografts against primary human AML disease and healthy hematopoietic cells.

Inez Johanna et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.